Selected research
Industry Research
Diclofenac Industry Research Report 2026
Market perspective
The global Diclofenac market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diclofenac is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diclofenac is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diclofenac is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diclofenac include Henan PANPAN, Henan Dongtai, Guangdong LongFine, Bayer, Xi'an Henrikang Biotech Co., Ltd., Simagchem Corp, ORIHERB, Nipa Pharmaceuticals and Metrix Healthcare, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diclofenac market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diclofenac Market by Company
Henan PANPAN
Henan Dongtai
Guangdong LongFine
Bayer
Xi'an Henrikang Biotech Co., Ltd.
Simagchem Corp
ORIHERB
Nipa Pharmaceuticals
Metrix Healthcare
Kairav Chemicals
Istituto Biochimico
Hunan Warrant
Auro Laboratories
Diclofenac Segment by Type
Oral
Parenteral
Diclofenac Segment by Application
Osteoarthritis
Rheumatoid Arthritis
Migraine
Ankylosing Spondylitis
Dysmenorrhea
Others
Diclofenac Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diclofenac market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diclofenac and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diclofenac.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diclofenac manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diclofenac by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diclofenac in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Parenteral
Applications
- Osteoarthritis
- Rheumatoid Arthritis
- Migraine
- Ankylosing Spondylitis
- Dysmenorrhea
- Others
Companies covered
- Henan PANPAN
- Henan Dongtai
- Guangdong LongFine
- Bayer
- Xi'an Henrikang Biotech Co., Ltd.
- Simagchem Corp
- ORIHERB
- Nipa Pharmaceuticals
- Metrix Healthcare
- Kairav Chemicals
- Istituto Biochimico
- Hunan Warrant
- Auro Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diclofenac Market Size (2021-2032)
- 2.2.2 Global Diclofenac Sales (2021-2032)
- 2.2.3 Global Diclofenac Market Average Price (2021-2032)
- 2.3 Diclofenac by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral
- 2.3.3 Parenteral
- 2.4 Diclofenac by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Osteoarthritis
- 2.4.3 Rheumatoid Arthritis
- 2.4.4 Migraine
- 2.4.5 Ankylosing Spondylitis
- 2.4.6 Dysmenorrhea
- 2.4.7 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diclofenac Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diclofenac Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Diclofenac Revenue of Manufacturers (2021-2026)
- 3.4 Global Diclofenac Average Price by Manufacturers (2021-2026)
- 3.5 Global Diclofenac Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diclofenac, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diclofenac, Product Type & Application
- 3.8 Global Manufacturers of Diclofenac, Established Date
- 3.9 Global Diclofenac Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Henan PANPAN
- 4.1.1 Henan PANPAN Company Information
- 4.1.2 Henan PANPAN Business Overview
- 4.1.3 Henan PANPAN Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Henan PANPAN Diclofenac Product Portfolio
- 4.1.5 Henan PANPAN Recent Developments
- 4.2 Henan Dongtai
- 4.2.1 Henan Dongtai Company Information
- 4.2.2 Henan Dongtai Business Overview
- 4.2.3 Henan Dongtai Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Henan Dongtai Diclofenac Product Portfolio
- 4.2.5 Henan Dongtai Recent Developments
- 4.3 Guangdong LongFine
- 4.3.1 Guangdong LongFine Company Information
- 4.3.2 Guangdong LongFine Business Overview
- 4.3.3 Guangdong LongFine Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Guangdong LongFine Diclofenac Product Portfolio
- 4.3.5 Guangdong LongFine Recent Developments
- 4.4 Bayer
- 4.4.1 Bayer Company Information
- 4.4.2 Bayer Business Overview
- 4.4.3 Bayer Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Bayer Diclofenac Product Portfolio
- 4.4.5 Bayer Recent Developments
- 4.5 Xi'an Henrikang Biotech Co., Ltd.
- 4.5.1 Xi'an Henrikang Biotech Co., Ltd. Company Information
- 4.5.2 Xi'an Henrikang Biotech Co., Ltd. Business Overview
- 4.5.3 Xi'an Henrikang Biotech Co., Ltd. Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Xi'an Henrikang Biotech Co., Ltd. Diclofenac Product Portfolio
- 4.5.5 Xi'an Henrikang Biotech Co., Ltd. Recent Developments
- 4.6 Simagchem Corp
- 4.6.1 Simagchem Corp Company Information
- 4.6.2 Simagchem Corp Business Overview
- 4.6.3 Simagchem Corp Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Simagchem Corp Diclofenac Product Portfolio
- 4.6.5 Simagchem Corp Recent Developments
- 4.7 ORIHERB
- 4.7.1 ORIHERB Company Information
- 4.7.2 ORIHERB Business Overview
- 4.7.3 ORIHERB Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 ORIHERB Diclofenac Product Portfolio
- 4.7.5 ORIHERB Recent Developments
- 4.8 Nipa Pharmaceuticals
- 4.8.1 Nipa Pharmaceuticals Company Information
- 4.8.2 Nipa Pharmaceuticals Business Overview
- 4.8.3 Nipa Pharmaceuticals Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Nipa Pharmaceuticals Diclofenac Product Portfolio
- 4.8.5 Nipa Pharmaceuticals Recent Developments
- 4.9 Metrix Healthcare
- 4.9.1 Metrix Healthcare Company Information
- 4.9.2 Metrix Healthcare Business Overview
- 4.9.3 Metrix Healthcare Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Metrix Healthcare Diclofenac Product Portfolio
- 4.9.5 Metrix Healthcare Recent Developments
- 4.10 Kairav Chemicals
- 4.10.1 Kairav Chemicals Company Information
- 4.10.2 Kairav Chemicals Business Overview
- 4.10.3 Kairav Chemicals Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Kairav Chemicals Diclofenac Product Portfolio
- 4.10.5 Kairav Chemicals Recent Developments
- 4.11 Istituto Biochimico
- 4.11.1 Istituto Biochimico Company Information
- 4.11.2 Istituto Biochimico Business Overview
- 4.11.3 Istituto Biochimico Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Istituto Biochimico Diclofenac Product Portfolio
- 4.11.5 Istituto Biochimico Recent Developments
- 4.12 Hunan Warrant
- 4.12.1 Hunan Warrant Company Information
- 4.12.2 Hunan Warrant Business Overview
- 4.12.3 Hunan Warrant Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hunan Warrant Diclofenac Product Portfolio
- 4.12.5 Hunan Warrant Recent Developments
- 4.13 Auro Laboratories
- 4.13.1 Auro Laboratories Company Information
- 4.13.2 Auro Laboratories Business Overview
- 4.13.3 Auro Laboratories Diclofenac Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Auro Laboratories Diclofenac Product Portfolio
- 4.13.5 Auro Laboratories Recent Developments
5 Global Diclofenac Market Scenario by Region
- 5.1 Global Diclofenac Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diclofenac Sales by Region: 2021-2032
- 5.2.1 Global Diclofenac Sales by Region: 2021-2026
- 5.2.2 Global Diclofenac Sales by Region: 2027-2032
- 5.3 Global Diclofenac Revenue by Region: 2021-2032
- 5.3.1 Global Diclofenac Revenue by Region: 2021-2026
- 5.3.2 Global Diclofenac Revenue by Region: 2027-2032
- 5.4 North America Diclofenac Market Facts & Figures by Country
- 5.4.1 North America Diclofenac Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diclofenac Sales by Country (2021-2032)
- 5.4.3 North America Diclofenac Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Diclofenac Market Facts & Figures by Country
- 5.5.1 Europe Diclofenac Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diclofenac Sales by Country (2021-2032)
- 5.5.3 Europe Diclofenac Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Diclofenac Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diclofenac Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diclofenac Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diclofenac Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diclofenac Market Facts & Figures by Country
- 5.7.1 South America Diclofenac Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diclofenac Sales by Country (2021-2032)
- 5.7.3 South America Diclofenac Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.7.7 Colombia
- 5.8 Middle East and Africa Diclofenac Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diclofenac Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diclofenac Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diclofenac Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Diclofenac Sales by Type (2021-2032)
- 6.1.1 Global Diclofenac Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Diclofenac Sales Market Share by Type (2021-2032)
- 6.2 Global Diclofenac Revenue by Type (2021-2032)
- 6.2.1 Global Diclofenac Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diclofenac Revenue Market Share by Type (2021-2032)
- 6.3 Global Diclofenac Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diclofenac Sales by Application (2021-2032)
- 7.1.1 Global Diclofenac Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Diclofenac Sales Market Share by Application (2021-2032)
- 7.2 Global Diclofenac Revenue by Application (2021-2032)
- 7.2.1 Global Diclofenac Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diclofenac Revenue Market Share by Application (2021-2032)
- 7.3 Global Diclofenac Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diclofenac Value Chain Analysis
- 8.1.1 Diclofenac Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diclofenac Production Mode & Process
- 8.2 Diclofenac Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diclofenac Distributors
- 8.2.3 Diclofenac Customers
9 Global Diclofenac Analyzing Market Dynamics
- 9.1 Diclofenac Industry Trends
- 9.2 Diclofenac Industry Drivers
- 9.3 Diclofenac Industry Opportunities and Challenges
- 9.4 Diclofenac Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst